# The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia

> **NCT03169348** · NA · UNKNOWN · sponsor: **Assiut University** · enrollment: 50 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** sofosbuvir daclatasvir
- **DRUG:** Ledipasvir/sofosbuvir

## Key facts

- **NCT ID:** NCT03169348
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2019-06
- **Final completion:** 2019-09
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2017-12-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03169348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03169348, "The Effect of Direct Antiviral Therapy on Hepatitis c Virus-related Thrombocytopenia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03169348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*